2030 Communication Pharmaceutical Companies 
pharmaphorum
MARCH 31, 2021
The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?
pharmaphorum
SEPTEMBER 22, 2021
While there has been incredible progress in the HIV response, nearly 38 million people are living with HIV, with more than a million new cases every year, jeopardising the goal to end AIDS as a public health threat by 2030. HIV places enormous burdens on the communities it affects most, straining health systems and government budgets.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JANUARY 20, 2023
Pharmaceutical companies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. In addition, a paper published in 2019, concluded that the pharmaceutical industry produced 48.55
Pharmaceutical Technology
DECEMBER 15, 2022
With its highly educated, English-speaking workforce and high-quality medical facilities system, Singapore has attracted leading pharmaceutical companies to open their regional headquarters in the city-state, including Novo Nordisk (Bagsvaerd, Denmark) and GSK. Please check your email to download the Report.
Pharmaceutical Technology
JUNE 8, 2023
AstraZeneca has announced its supply chain will be carbon negative by 2030. Of the world’s 20 largest pharmaceutical companies, 17 have launched programmes tailored towards increasing medication access in low- and middle-income countries – up from just eight in 2010. A similar theme is evident in company filings.
Pharmaceutical Technology
DECEMBER 22, 2022
By 2030, JCAs will be carried out on all medicinal products with an EMA-issued MA. Visit our privacy policy for more information about our services, how we may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
Pharmaceutical Technology
JUNE 15, 2023
Generic and biosimilar pharmaceutical company and Novartis subsidiary Sandoz announced its plan to accelerate patient access to biosimilars. In a 15 June statement, Sandoz said that it hoped the Act4Biosimilars action plan will provide actionable solutions to overcome barriers preventing patient access to biosimilars.
Expert insights. Personalized for you.
98 
Let's personalize your content